Van Amsterdam et al. present the first set of empirical findings relating to generic drug legislation in the UK and Germany, revealing it to be largely ineffective in counteracting NPS use and causing increased public health problems.
Harm Reduction International expose the large sums of aid being spent on drug prohibition worldwide, calling on governments and donors to divest from punitive policies and invest in health and human rights.
Van Selm et al. highlight the considerable lack of data regarding migrants who use drugs and their access to drug dependency services, with 15 recommendations designed to improve data collection and service accessibility and availability,
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
WHO improves its information-sharing process by introducing a new single-source repository, representing the only online, freely accessible collection of information and reports on new psychoactive substances and medicines.